Skip to Content
Merck
CN
  • Hsa_circ_0007494 suppresses prostate cancer progression via miR-616/PTEN axis.

Hsa_circ_0007494 suppresses prostate cancer progression via miR-616/PTEN axis.

Experimental cell research (2020-08-19)
Shilong Zhang, Xiangsheng Zhang, Guoxiao Chen, Xiaokang Zheng, Xiaobo Zhu, Lei Shan
ABSTRACT

Circular RNAs (circRNAs) are important players in prostate cancer (PCa) development and progression, but their detailed mechanisms have not been elucidated. Herein, hsa_circ_0007494 was suppressed in the PCa cell lines and tissues. This resulted in metastasis of tumors to the lymph node and predicted tumor stage. Functionally, overexpression of hsa_circ_0007494 inhibited the proliferation and invasive capacity of the cells in vitro and blocked the growth of tumors in vivo. Hsa_circ_0007494 functioned as a "molecular sponge" for miR-616 and hence upregulated the target of miR-616, PTEN. In addition, rescue assays revealed that PTEN silencing (or miR-616 mimics) blocked the tumor-suppressing effects of hsa_circ_0007494 overexpression on PCa progression. Together, our findings indicate that hsa_circ_0007494 suppresses PCa by forming a negative regulatory network including hsa_circ_0007494/miR-616/PTEN. Thus, hsa_circ_0007494 may be a treatment target for PCa.